vs

Side-by-side financial comparison of Citizens Community Bancorp Inc. (CZWI) and AVITA Medical, Inc. (RCEL). Click either name above to swap in a different company.

AVITA Medical, Inc. is the larger business by last-quarter revenue ($17.6M vs $15.8M, roughly 1.1× Citizens Community Bancorp Inc.). Citizens Community Bancorp Inc. runs the higher net margin — 27.1% vs -66.0%, a 93.1% gap on every dollar of revenue. On growth, Citizens Community Bancorp Inc. posted the faster year-over-year revenue change (14.9% vs -4.3%). Citizens Community Bancorp Inc. produced more free cash flow last quarter ($10.4M vs $-6.1M). Over the past eight quarters, AVITA Medical, Inc.'s revenue compounded faster (26.0% CAGR vs 1.9%).

Glacier Bancorp, Inc. is a regional multi-bank holding company headquartered in Kalispell, Montana, United States. It is a successor corporation to the Delaware corporation originally incorporated in 1990. The company provides personal and commercial banking services from 221 locations in Montana, Idaho, Utah, Washington, Wyoming, Colorado, Arizona, and, Nevada.

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East...

CZWI vs RCEL — Head-to-Head

Bigger by revenue
RCEL
RCEL
1.1× larger
RCEL
$17.6M
$15.8M
CZWI
Growing faster (revenue YoY)
CZWI
CZWI
+19.2% gap
CZWI
14.9%
-4.3%
RCEL
Higher net margin
CZWI
CZWI
93.1% more per $
CZWI
27.1%
-66.0%
RCEL
More free cash flow
CZWI
CZWI
$16.5M more FCF
CZWI
$10.4M
$-6.1M
RCEL
Faster 2-yr revenue CAGR
RCEL
RCEL
Annualised
RCEL
26.0%
1.9%
CZWI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CZWI
CZWI
RCEL
RCEL
Revenue
$15.8M
$17.6M
Net Profit
$4.3M
$-11.6M
Gross Margin
81.2%
Operating Margin
31.0%
-59.1%
Net Margin
27.1%
-66.0%
Revenue YoY
14.9%
-4.3%
Net Profit YoY
58.1%
-0.3%
EPS (diluted)
$0.44
$-0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CZWI
CZWI
RCEL
RCEL
Q4 25
$15.8M
$17.6M
Q3 25
$16.2M
$17.1M
Q2 25
$16.1M
$18.4M
Q1 25
$14.2M
$18.5M
Q4 24
$13.7M
$18.4M
Q3 24
$14.2M
$19.5M
Q2 24
$13.5M
$15.2M
Q1 24
$15.2M
$11.1M
Net Profit
CZWI
CZWI
RCEL
RCEL
Q4 25
$4.3M
$-11.6M
Q3 25
$3.7M
$-13.2M
Q2 25
$3.3M
$-9.9M
Q1 25
$3.2M
$-13.9M
Q4 24
$2.7M
$-11.6M
Q3 24
$3.3M
$-16.2M
Q2 24
$3.7M
$-15.4M
Q1 24
$4.1M
$-18.7M
Gross Margin
CZWI
CZWI
RCEL
RCEL
Q4 25
81.2%
Q3 25
81.3%
Q2 25
81.2%
Q1 25
84.7%
Q4 24
87.6%
Q3 24
83.7%
Q2 24
86.1%
Q1 24
86.4%
Operating Margin
CZWI
CZWI
RCEL
RCEL
Q4 25
31.0%
-59.1%
Q3 25
27.9%
-53.6%
Q2 25
25.1%
-60.5%
Q1 25
28.0%
-63.9%
Q4 24
24.5%
-54.1%
Q3 24
29.5%
-70.6%
Q2 24
35.0%
-102.8%
Q1 24
34.2%
-155.0%
Net Margin
CZWI
CZWI
RCEL
RCEL
Q4 25
27.1%
-66.0%
Q3 25
22.7%
-77.3%
Q2 25
20.3%
-53.9%
Q1 25
22.5%
-74.9%
Q4 24
19.7%
-63.0%
Q3 24
23.1%
-82.9%
Q2 24
27.2%
-101.3%
Q1 24
26.9%
-168.0%
EPS (diluted)
CZWI
CZWI
RCEL
RCEL
Q4 25
$0.44
$-0.37
Q3 25
$0.37
$-0.46
Q2 25
$0.33
$-0.38
Q1 25
$0.32
$-0.53
Q4 24
$0.28
$-0.44
Q3 24
$0.32
$-0.62
Q2 24
$0.35
$-0.60
Q1 24
$0.39
$-0.73

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CZWI
CZWI
RCEL
RCEL
Cash + ST InvestmentsLiquidity on hand
$118.9M
$18.2M
Total DebtLower is stronger
$51.8M
Stockholders' EquityBook value
$187.9M
$-16.6M
Total Assets
$1.8B
$56.4M
Debt / EquityLower = less leverage
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CZWI
CZWI
RCEL
RCEL
Q4 25
$118.9M
$18.2M
Q3 25
$82.4M
$23.3M
Q2 25
$67.5M
$15.7M
Q1 25
$100.2M
$25.8M
Q4 24
$50.2M
$35.9M
Q3 24
$36.6M
$44.4M
Q2 24
$36.9M
$54.1M
Q1 24
$28.6M
$68.2M
Total Debt
CZWI
CZWI
RCEL
RCEL
Q4 25
$51.8M
Q3 25
Q2 25
Q1 25
Q4 24
$66.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CZWI
CZWI
RCEL
RCEL
Q4 25
$187.9M
$-16.6M
Q3 25
$186.8M
$-6.7M
Q2 25
$183.5M
$-12.9M
Q1 25
$180.1M
$-4.6M
Q4 24
$179.1M
$4.5M
Q3 24
$180.1M
$12.2M
Q2 24
$176.0M
$23.9M
Q1 24
$172.8M
$32.6M
Total Assets
CZWI
CZWI
RCEL
RCEL
Q4 25
$1.8B
$56.4M
Q3 25
$1.7B
$63.7M
Q2 25
$1.7B
$58.1M
Q1 25
$1.8B
$69.6M
Q4 24
$1.7B
$79.7M
Q3 24
$1.8B
$81.1M
Q2 24
$1.8B
$87.8M
Q1 24
$1.8B
$97.4M
Debt / Equity
CZWI
CZWI
RCEL
RCEL
Q4 25
0.28×
Q3 25
Q2 25
Q1 25
Q4 24
0.37×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CZWI
CZWI
RCEL
RCEL
Operating Cash FlowLast quarter
$11.7M
$-5.4M
Free Cash FlowOCF − Capex
$10.4M
$-6.1M
FCF MarginFCF / Revenue
65.9%
-34.7%
Capex IntensityCapex / Revenue
8.3%
3.8%
Cash ConversionOCF / Net Profit
2.74×
TTM Free Cash FlowTrailing 4 quarters
$17.5M
$-33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CZWI
CZWI
RCEL
RCEL
Q4 25
$11.7M
$-5.4M
Q3 25
$6.6M
$-5.2M
Q2 25
$-406.0K
$-10.2M
Q1 25
$1.6M
$-10.3M
Q4 24
$20.4M
$-8.1M
Q3 24
$3.5M
$-7.2M
Q2 24
$5.1M
$-12.8M
Q1 24
$9.1M
$-20.9M
Free Cash Flow
CZWI
CZWI
RCEL
RCEL
Q4 25
$10.4M
$-6.1M
Q3 25
$6.2M
$-6.2M
Q2 25
$-632.0K
$-10.8M
Q1 25
$1.5M
$-10.5M
Q4 24
$19.5M
$-9.7M
Q3 24
$3.4M
$-11.0M
Q2 24
$4.8M
$-15.4M
Q1 24
$8.9M
$-22.0M
FCF Margin
CZWI
CZWI
RCEL
RCEL
Q4 25
65.9%
-34.7%
Q3 25
38.4%
-36.1%
Q2 25
-3.9%
-58.4%
Q1 25
10.7%
-56.9%
Q4 24
142.2%
-52.7%
Q3 24
23.8%
-56.1%
Q2 24
35.7%
-101.6%
Q1 24
58.9%
-198.2%
Capex Intensity
CZWI
CZWI
RCEL
RCEL
Q4 25
8.3%
3.8%
Q3 25
2.4%
5.5%
Q2 25
1.4%
2.8%
Q1 25
0.7%
1.2%
Q4 24
6.5%
8.8%
Q3 24
0.9%
19.2%
Q2 24
2.3%
17.5%
Q1 24
1.4%
10.3%
Cash Conversion
CZWI
CZWI
RCEL
RCEL
Q4 25
2.74×
Q3 25
1.80×
Q2 25
-0.12×
Q1 25
0.50×
Q4 24
7.55×
Q3 24
1.07×
Q2 24
1.39×
Q1 24
2.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons